Subscribe to Zinmag Tribune
Subscribe to Zinmag Tribune
Subscribe to Zinmag Tribune by mail

Suven Life Sciences jumped 19.92% to Rs 31.60 at 10:00 IST on BSE, after the company said it is in talks with four global Pharma major for out-licensing deals for its Alzheimer drug SUVN-502, which is in the developing stage.
You can leave a response, or trackback from your own site.

featured-video

Blog Archive

Recent Posts

My Blog List